Pharmaceutical News

RSS

Biobank Data can Provide Insights into Genetic Architecture of Drug Response

A UCLA study has outlined a new framework that researchers say would improve predictive power of genetics to determine how well a patient would respond to commonly prescribed medications as well as the severity of any side effects.

5 Dec 2024

African Wormwood Identified as Potential Weapon Against Drug-Resistant Tuberculosis

The mechanisms through which A. afra fights M. tuberculosis.

14 Oct 2024

Microbiotica Secures Approvals to Begin Clinical Studies in EU and UK for New Microbiome Medicines

Microbiotica, a biopharma company developing a pipeline of oral precision microbiome medicines called live biotherapeutic products (LBPs), is pleased to announce that it has received regulatory approvals to initiate clinical studies for its first two programmes in advanced melanoma (MELODY-1) and ulcerative colitis (COMPOSER-1) in selected EU countries and the UK. Both studies are due to start shortly, with initial data readouts expected by the end of 2025.

30 Aug 2024

European Commission Approves Erdafitinib for Advanced Urothelial Carcinoma

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved BALVERSA®▼(erdafitinib) as a once-daily oral monotherapy for the treatment of adult patients with unresectable or metastatic urothelial carcinoma (mUC), harbouring susceptible fibroblast growth factor receptor 3 (FGFR3) genetic alterations who have previously received at least one line of therapy containing a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor in the unresectable or metastatic treatment setting.

30 Aug 2024

RYBREVANT Receives EC Nod for Advanced Lung Cancer Treatment

Janssen-Cilag International NV, a Johnson & Johnson company, today announced that the European Commission (EC) has approved a Type II extension of indication for RYBREVANT®▼ (amivantamab) in combination with chemotherapy (carboplatin and pemetrexed), for the treatment of adults with advanced non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) Exon 19 deletions (ex19del) or Exon 21 L858R substitution (L858R) mutations, after failure of prior therapy including an EGFR tyrosine kinase inhibitor (TKI).

30 Aug 2024

RNA Interference Drugs Offer Faster, More Effective Alternative to Traditional Drug Discovery

Alnylam's RNA interference platform accelerates drug discovery by targeting RNA transcripts, addressing complex diseases with innovative therapeutic strategies.

28 Aug 2024

Surface Plasmon Resonance Sensors: Transforming Drug Development and Clinical Diagnostics

The latest developments in SPR-based biosensors and their applications in drug discovery.

15 Jul 2024

Artificial Intelligence Drives Breakthroughs in Drug Discovery, Reducing Costs and Timelines

Researchers discussed using deep generative AI models and their diverse algorithms in de novo drug design.

12 Jul 2024

Liver-on-Chips: Innovations, Applications, and Challenges in Drug Development

The development and application of liver-on-chips and the factors preventing its widespread use in drug discovery.

12 Jul 2024

3D Cell Cultures Improve Drug Screening Accuracy but Show Lower Efficacy for Anti-Cancer Drugs

The existing knowledge on monolayers and spheroid-based cell cultures, including the constituent compounds, and the difference in efficacy during drug screening, especially for anti-cancer drugs targeting cytoskeletal dynamics and cell cycles.

21 Jun 2024

CARA Benchmark Set to Revolutionize Data-Driven Drug Discovery Methods

A compound activity prediction benchmark they curated for real-world, practical applications called Compound Activity benchmark for Real-world Applications (CARA).

11 Jun 2024

Immune Checkpoint Inhibitors Confer a Protective Effect on Bone by Promoting Osteogenesis

Immune checkpoint inhibitors (ICIs), widely employed anticancer agents, have been found to impact bone turnover, potentially conferring a protective effect on bone through the promotion of osteogenesis.

3 Jun 2024

Mesenchymal stem cell-derived exosomes carrying vincristine sulfate are effective in killing cancer stem cells

Whether loading vincristine sulfate into mesenchymal stem cell-derived exosomes could improve the targeted delivery of the drug specifically to cancer stem cells.

21 May 2024

New Horizons in Chemical Biology: A Novel Approach to Synthesize Dibenzothiophene S-Oxides

Dibenzothiophene S-oxides are important in various biochemical processes. However, their synthesis using conventional methods is not easy.

30 Jan 2024

Validant Group of Companies Unite as ELIQUENT Life Sciences

The Validant Group of companies today announced a strategic repositioning that unites the five companies as one global regulatory brand: ELIQUENT Life Sciences.

From ELIQUENT Life Sciences 10 Jan 2024

Johnson Matthey Announces Partnership With Basecamp Research to Accelerate the Adoption of Biocatalysis Solutions

Johnson Matthey (JM), a global leader in sustainable technologies, and Basecamp Research, a leader in mapping biodiversity for computational bio-design, today announced their partnership to accelerate the adoption of more sustainable, bio-based catalysts.

From Johnson Matthey 5 Dec 2023

High Levels of Exposure to the Virus Causing COVID-19 May Reduce Safety Given by Vaccination

High levels of exposure to the virus that causes COVID-19 may reduce or overcome the protection that vaccination and prior infection provides, according to a new study by researchers from Yale University, the University of Florida, and the Connecticut Department of Correction.

24 Aug 2023

Innovative Method Accelerates Discovery of New Drugs by Harnessing the Power of Ribosomes

A research team led by University of California, Irvine scientists has developed an innovative method for quickly and efficiently creating vast collections of chemical compounds used in drug discovery by harnessing the power of ribosomes, the molecules found in all cells that synthesize proteins and peptides.

24 Aug 2023

The BioICEP Project Turns Non-Biodegradable Plastics into New Biobased Materials for the Packaging and Pharmaceutical Industries

AIMPLAS, the Plastics Technology Centre, forms part of the BioICEP project (Bio Innovation of a Circular Economy for Plastics), which started in February 2020 and is funded by the Horizon 2020 program.

23 Aug 2023

Analyzing the First Vaccine Against Respiratory Syncytial Virus in Many Older Adults

The first Americans over age 60 just started rolling up their sleeves to get vaccinated against respiratory syncytial virus, or RSV, now that brand-new vaccines have started to arrive at pharmacies and clinics.

23 Aug 2023

Pharmaceutical News

Biobank Data can Provide Insights into Genetic Architecture of Drug Response

African Wormwood Identified as Potential Weapon Against Drug-Resistant Tuberculosis

Microbiotica Secures Approvals to Begin Clinical Studies in EU and UK for New Microbiome Medicines

European Commission Approves Erdafitinib for Advanced Urothelial Carcinoma

RYBREVANT Receives EC Nod for Advanced Lung Cancer Treatment

RNA Interference Drugs Offer Faster, More Effective Alternative to Traditional Drug Discovery

Surface Plasmon Resonance Sensors: Transforming Drug Development and Clinical Diagnostics

Artificial Intelligence Drives Breakthroughs in Drug Discovery, Reducing Costs and Timelines

Liver-on-Chips: Innovations, Applications, and Challenges in Drug Development

3D Cell Cultures Improve Drug Screening Accuracy but Show Lower Efficacy for Anti-Cancer Drugs

CARA Benchmark Set to Revolutionize Data-Driven Drug Discovery Methods

Immune Checkpoint Inhibitors Confer a Protective Effect on Bone by Promoting Osteogenesis

Mesenchymal stem cell-derived exosomes carrying vincristine sulfate are effective in killing cancer stem cells

New Horizons in Chemical Biology: A Novel Approach to Synthesize Dibenzothiophene S-Oxides

Validant Group of Companies Unite as ELIQUENT Life Sciences

Johnson Matthey Announces Partnership With Basecamp Research to Accelerate the Adoption of Biocatalysis Solutions

High Levels of Exposure to the Virus Causing COVID-19 May Reduce Safety Given by Vaccination

Innovative Method Accelerates Discovery of New Drugs by Harnessing the Power of Ribosomes

The BioICEP Project Turns Non-Biodegradable Plastics into New Biobased Materials for the Packaging and Pharmaceutical Industries

Analyzing the First Vaccine Against Respiratory Syncytial Virus in Many Older Adults

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics